Related Experiment Video
Updated: Mar 13, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
HCV Inhibitors: Role of Compounds from Botanical Sources
Vaishali M Patil1, Neeraj Masand, Satya Prakash Gupta
1Medicinal Chemistry Research Laboratory, School of Pharmacy, Bharat Institute of Technology, Meerut-250 103 Uttar Pradesh, India. vaishalimasand@hotmail.com.
Abstract:
The developing number of hepatitis C virus infected cases worldwide has threatened people's health. The available therapeutic options have low specificity, side effects and high rate of drug resistance and thus potentiate the need for novel effective anti-HCV drugs. Agents obtained from natural sources offer an enormous scope of structural diversity and broad therapeutic range of coverage. This review summarizes the research and development of anti-HCV agents (plant extracts/isolated components) obtained from various natural sources along with the associated mechanism of HCV inhibition. Some of the reported examples include triterpenes, naringenin, Proanthocyanidin, curcumin, Epigallocatechin-3-gallate, quercetin and abrogates having diverse anti-HCV properties. The compiled knowledge regarding anti-HCV agents from natural sources will provide considerable information for developing novel safe and effective anti-HCV drugs.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Subviral Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hepatic Drug Excretion: Influencing Factors
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hepatic Drug Clearance: Role of Transporters

